Somatostatin May Enhance Cytotoxic Effect of Doxorubicin on Gallbladder Cancer Cells

Li Ji-yu,Quan Zhi-wei,Zhang Qiang,Liu Jian-wen
DOI: https://doi.org/10.1007/s11670-004-0040-8
2004-01-01
Abstract:Objective: To explore the change of chemosensitivity of gallbladder cancer cells pre-treated with somatostatin. Methods: Twenty-four hours after somatostatin treatment, gradient concentrated Doxorubicin was added and growth curve of gallbladder cancer cells was investigated to measure IC 50 , i.e., concentration of Doxorubicin at 50% cell viability. Results: Somatostatin ccould induce gallbladder cancer cell growth arrest in S phase. Inhibition of growth of cancer cell line was detected by Doxorubicin concentration- dependently ( P <0.05). IC 50 value was significantly lower by combined-treating with somatostatin and Doxorubicin compared with by Doxorubicin alone ( P <0.05). Conclusion: Somatostatin could increase the cytotoxic effect of Doxorubicin on gallbladder cancer cell by modulating its cell cycle.
What problem does this paper attempt to address?